ArticleCancers2021

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer.

Joaquim Bosch-Barrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.